Inogen Inc. (NASDAQ: INGN) announced three executive appointments as the medical technology company restructures its leadership team.

Jason Richardson will join as chief financial officer on April 6, 2026, replacing Michael Bourque, who will step down and serve in an advisory capacity through June 30, 2026. Richardson previously served as CFO and vice president of Baxter International Inc.'s Healthcare Systems & Technologies segment, a $3 billion business unit.

Dominic Hulton has been appointed chief marketing officer, effective April 1, 2026, in a newly created role. Hulton spent 11 years at Insulet Corporation, where he served as vice president of international marketing and sales excellence.

Corey Moritz joined the company March 9, 2026, as vice president of U.S. business-to-business sales. Moritz previously served as chief commercial officer at Rhythm Healthcare.

"Jason's deep expertise in finance and operations across the medical device and healthcare industries will be instrumental as we focus on delivering superior respiratory solutions to patients around the world and driving sustainable growth," said Kevin Smith, president and CEO of Inogen.

The company also reaffirmed its first quarter and full year 2026 financial outlook that was provided in its fourth quarter and full year 2025 earnings release issued February 24, 2026.

Inogen develops and manufactures respiratory therapy devices for patients with chronic respiratory conditions in homecare settings.